CD274 and cancer: On the basis of the above findings, the authors further explored the utility of STM108 as an antibody-drug conjugate (ADC) containing an anti-mitotic drug monomethyl auristatin E, which exhibits bystander effects, to induce potent toxicity to eradicate TNBC by inhibiting surrounding cancer cells that have low or no PD-L1 expression [36].